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ORIGINAL ARTICLE
TUB gene expression in hypothalamus and adipose tissue and
its association with obesity in humans
VJM Nies1, D Struik1, MGM Wolfs2, SS Rensen3, E Szalowska4, UA Unmehopa5, K Fluiter6, TP van der Meer2, G Hajmousa7, WA Buurman8,
JW Greve9, F Rezaee4, R Shiri-Sverdlov10, RJ Vonk4, DF Swaab11, BHR Wolffenbuttel2, JW Jonker1,13 and JV van Vliet-Ostaptchouk2,12,13
BACKGROUND/OBJECTIVES: Mutations in the Tubby gene (TUB) cause late-onset obesity and insulin resistance in mice and
syndromic obesity in humans. Although TUB gene function has not yet been fully elucidated, studies in rodents indicate that TUB is
involved in the hypothalamic pathways regulating food intake and adiposity. Aside from the function in central nervous system,
TUB has also been implicated in energy metabolism in adipose tissue in rodents. We aimed to determine the expression and
distribution patterns of TUB in man as well as its potential association with obesity.
SUBJECTS/METHODS: In situ hybridization was used to localize the hypothalamic regions and cells expressing TUB mRNA. Using
RT–PCR, we determined the mRNA expression level of the two TUB gene alternative splicing isoforms, the short and the long
transcript variants, in the hypothalami of 12 obese and 12 normal-weight subjects, and in biopsies from visceral (VAT) and
subcutaneous (SAT) adipose tissues from 53 severely obese and 24 non-obese control subjects, and correlated TUB expression with
parameters of obesity and metabolic health.
RESULTS: Expression of both TUB transcripts was detected in the hypothalamus, whereas only the short TUB isoform was found in
both VAT and SAT. TUB mRNA was detected in several hypothalamic regions involved in body weight regulation, including the
nucleus basalis of Meynert and the paraventricular, supraoptic and tuberomammillary nuclei. We found no difference in the
hypothalamic TUB expression between obese and control groups, whereas the level of TUBmRNA was significantly lower in adipose
tissue of obese subjects as compared to controls. Also, TUB expression was negatively correlated with indices of body weight and
obesity in a fat-depot-specific manner.
CONCLUSIONS: Our results indicate high expression of TUB in the hypothalamus, especially in areas involved in body weight
regulation, and the correlation between TUB expression in adipose tissue and obesity. These findings suggest a role for TUB in
human obesity.
International Journal of Obesity (2018) 42, 376–383; doi:10.1038/ijo.2017.214
INTRODUCTION
The TUB gene encodes the Tubby protein, which is found in a
wide range of organisms across the animal and plant kingdom,
suggesting an evolutionarily conserved biological function.1 TUB
was initially discovered through positional cloning of a sponta-
neous mutation that led to obesity in a mice breeding colony at
The Jackson Laboratories.2–5 Mice carrying this mutation (later
designated as Tubby mice) have obesity, insulin resistance and
neurosensory deficits.2 Compared with other murine models of
obesity such as leptin-deficient (ob/ob) and leptin receptor-
deficient (db/db) mice, the obesity in Tubby mice is relatively
mild, late in onset and associated with transient alterations in
glucose homeostasis.2 The similarity of the Tubby phenotype with
common obesity in the human population suggests that the TUB
gene may be involved in the pathogenesis of obesity in humans
as well.
Despite the TUB gene’s evident physiological relevance to
obesity, its exact molecular function remains enigmatic. Based on
the protein structure, it has been hypothesized that Tubby is a
transcription factor,1 whereas functional data suggest that Tubby
is an integrator of insulin and leptin signaling and/or of GPCR (G-
protein-coupled receptor) trafficking.6–8 However, so far none of
these studies have been completely conclusive. In rodents, TUB is
abundantly expressed in several areas of the hypothalamus,7,9,10 a
brain region critical in the regulation of appetite and energy
expenditure by the central nervous system (CNS).11 Studies of
Tubby mice have reported alterations in the hypothalamic
pathways related to feeding behavior12–14 and the defects in
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ciliary GPCR trafficking in the central neurons.15,16 From a young
age, Tubby mice show reductions in daily food intake and physical
activity, which in the end result in a net positive energy balance
and weight gain over time, whereas older obese mice develop
hyperphagia.12,17 There are also indications of abnormal carbohy-
drate metabolism in Tubby mice owing to defects in neuronal
innervation of the liver,14,18 resulting in increased fat deposition.18
Similarly, deletion of the Tubby orthologue tub-1 in Caenorhabditis
elegans leads to fat accumulation.19 Taken together, these data
indicate an evolutionarily conserved role for TUB in the regulation
of energy metabolism. Besides its expression in the CNS, in
rodents TUB is also known to be expressed in adipocytes, where it
may be involved in controlling peripheral insulin-sensitivity.20 The
extent to which the expression of TUB in adipose tissue
contributes to the Tubby phenotype is, however, still unclear.
To date, only a few studies have been done in humans
regarding TUB’s function and whether or not it might be involved
in obesity. We have previously shown that common variation in
the TUB gene is associated with body weight21,22 and macro-
nutrient intake (that is, higher carbohydrate consumption),22
whereas others have reported the TUB mutation to cause retinal
dystrophy and syndromic obesity.23 So far, the precise role of TUB
in metabolic regulation in humans is still undefined.
In an attempt to better understand the role for TUB in energy
homeostasis and disease in humans, we determined the expres-
sion and distribution patterns of TUB in the hypothalamus and in
adipose tissue, two tissues that are highly relevant in the context
of metabolic regulation and obesity. We also examined whether
and how TUB expression correlates with several parameters of
metabolic health and body weight in obese and healthy control
individuals. Finally, we assessed TUB expression during adipogen-
esis in vitro and investigated whether TUB expression in human
adipocytes can be modulated by metabolic hormones.
MATERIALS AND METHODS
Hypothalamus tissues from human subjects
Post-mortem hypothalamic material was obtained by autopsy. The first
subset of formalin-fixed and paraffin-embedded hypothalamic samples
from the subjects without neurological or psychiatric disease (n= 6) was
used to assess TUB mRNA distribution using in situ hybridization. A second
subset containing the frozen hypothalamic material of 12 pairs of obese
(body mass index (BMI) 430) and normal-weight control subjects
(BMIo25), matched for sex, age, clinical diagnosis and Braak stage of
Alzheimer progression,24 was used to examine TUB mRNA expression
levels. The samples were processed within a time range of 3:15–19:35 h of
post-mortem delay. All brain samples were obtained from The Netherlands
Brain Bank (NBB), Netherlands Institute for Neuroscience, Amsterdam
(director Dr Inge Huitinga, open access: www.brainbank.nl). All material
had been collected from donors for or from whom the NBB had obtained
written informed consent for a brain autopsy and the use of the material
and clinical information for research purposes.
TUB in situ hybridization
LNA probe. A locked nucleic acid (LNA) LNA-2’-O-methyl-RNA probe
specific for the human TUB mRNA was designed. LNA-2’-O-methyl-RNA
nucleic acid analogs were used because of their stability and high
hybridization affinity, and because of their successful application in
the human brain.25–27 An antisense probe was used (sequence:
5′-lTmUmAlCmUmAlTmUmUlAmGmClTmGmGlGmAmGlG-3′) that is com-
plementary to bases 1035–1053 of the long isoform of the human TUB
gene (RefSeq NM_003320.4) and to bases 778–796 of the short TUB
isoform (RefSeq NM_177972.2), wherein ‘m’=2’-O-methyl-RNA and ‘l’=
LNA bases (Supplementary Figure 1). Probe specificity was assessed using
a scrambled probe containing the same nucleotides but in random order
(sequence: 5′-lGmGmClTmUmUlAmGmAlTmGmClGmGmUlTmAmAlT-3′),
and by testing a concentration gradient ranging from 25 nM to 500 nM.
Probes were FAM tagged at the 5’-end and custom ordered (Ribotask,
Denmark).
In situ hybridization. Hypothalami were dissected during autopsy and
fixed in 10% (v/v) phosphate-buffered formalin at room temperature (RT).
The dissection borders of the hypothalamus were as follows: frontal cut
before the optic chiasm and behind the mammillary bodies, lateral cuts
1.5 cm from the midline, horizontal cut at the level of the anterior
commissure. After dehydration in graded ethanol series, tissues were
cleared in toluene and embedded in paraffin. Coronal serial sections (6 μm)
were cut over the entire rostro–caudal axis. Each 100th section was
collected, mounted on Superfrost Plus slides (Menzel Glaser, Braunschweig,
Germany) and subsequently dried for 2 days at 37 °C. The in situ
hybridization procedure was performed as described in detail in
Supplementary Text. In total, 120 s were included in the experiment. Ten
in situ hybridization runs were performed, with 12 sections per run.
Gene expression analysis. Frozen human hypothalami were homogenized
in liquid nitrogen. For further details see Supplementary Text. RNA quantity
was measured on a NanoDrop. RNA metrics such as peak heights, peak
areas and concentration are used to determine an RNA Quality Score (RQS)
number for each sample using LabChip GX (Caliper, PerkinElmer, Waltham,
MA, USA). The RQS has been validated to correlate well with Agilent’s RIN
(RNA Integrity Number) and follows the same 0–10 scale rating (with 10
being the highest). TUB expression was normalized to the 36B4 gene (also
known as RPLP0), which was selected from our test of five different
housekeeping genes previously reported to be the most stable in human
CNS post-mortem tissue.28 Relative expression was calculated using the Δ
[Δ (CT)] method.
29
Primers. mRNA reference sequences were obtained from the NCBI
website (http://www.ncbi.nlm.nih.gov.), and the mRNA levels for the long
and short isoforms of the TUB gene were determined using a primer set
designed by Primer3 software (http://frodo.wi.mit.edu/cgi-bin/primer3/
primer3.cgi): the forward primers were 5′-CCAGGAGGAAGTACTGGAAGG-3′
for the long isoform and 5′-ATGACTTCCAAGCCGCATT-3′ for the short
isoform; the reverse primer was 5′-TTCTGCTGCCTCAGGTTTCT-3′ for both
isoforms.
Adipose tissue material
Control samples. The control samples included in this study were
originally obtained from 24 Caucasian women who had undergone
surgery owing to benign gynecological problems.30 The subcutaneous
adipose tissue (SAT) and visceral adipose tissue (VAT) biopsies were taken
by means of scissors at the place of the incision, midline lower abdomen
above the symphysis and under the umbilicus (VAT) and at the lower edge
of the omentum (SAT). The AT samples were snap-frozen in liquid nitrogen
and stored at − 80 °C. For this study, the collection of SAT (n= 18) and VAT
(n=21) biopsies was used (for 15 subjects both SAT and VAT tissue was
available). Research subjects were in good health with no history or
symptoms of type 2 diabetes or inflammatory diseases. Subjects were
between 30 and 45 years of age, with BMI ranging from 23 to 29 kg m− 2.
Samples from obese individuals. The 53 severely obese individuals (BMI
ranging from 30 to 74 kg m− 2) included in this study had undergone
elective bariatric surgery at the Department of General Surgery, Maastricht
University Medical Centre.31 We excluded samples taken from subjects
with acute or chronic inflammatory diseases, or degenerative diseases, and
those reporting an alcohol intake exceeding 10 g per day or the use of
anti-inflammatory drugs. The sampling of VAT (n=46) and SAT (n= 41)
tissues (n= 34 with both VAT and SAT) obtained during bariatric surgery
has been described before.31 In short, venous blood samples were
obtained on the morning of surgery, whereas wedge biopsies of VAT
(omentum majus) and SAT (abdominal) were taken during surgery.
In both controls and obese patients, fasting blood samples were
collected for biochemical measurements.
Gene expression analysis. RNA was isolated using the Qiagen Lipid Tissue
Mini Kit (#74804, Qiagen). RNA concentration was determined with
NanoDrop. cDNA synthesis was performed from total RNA with QuantiTect
Reverse Transcription Kit (Qiagen) according to the manufacturer’s
instructions. 20 ng cDNA was used for subsequent RT–PCR analysis using
SYBR Green (Biorad, Veenendaal, The Netherlands) and 7900HT real-time
PCR System (ThermoFisher, Etten-Leur, The Netherlands). Data were
analyzed with SDS 2.0 software (Applied Biosystems). TUB mRNA levels
were expressed relative to those of the beta-2 microglobulin housekeeping
TUB gene expression study in humans
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gene (B2M), as the geNorm VBA applet for Microsoft Excel32 determined
B2M to be more stable than other common housekeeping genes.
ASC experiments
ASC isolation, culture and differentiation. Human subcutaneous lipoaspi-
rate samples were obtained from healthy human subjects (BMIo30, non-
diabetic) during liposuction surgery (Bergman Clinics, Heerenveen and
Zwolle, The Netherlands). The details on adipose-derived stromal cells (ASCs)
isolation, culture and differentiation are provided in Supplementary Text.
Gene expression analysis. Total RNA was isolated using Trizol according to
the manufacturer’s protocol. cDNA was synthesized and RT–PCR was
performed as described for the hypothalami. Gene expression levels were
normalized to 36B4.
All participants provided written informed consent and all procedures
were performed in accordance with national and institutional guidelines
and with the ethical guidelines of the Declaration of Helsinki.
Statistical analysis
Continuous variable data were presented as mean± s.e. unless stated
otherwise. Spearman's rho test was used to examine correlations.
Expression differences between the groups were statistically evaluated
by the nonparametric Mann–Whitney U-test or by the paired Student’s
t-test (between SAT and VAT). Graphs were computed with GraphPad
Prism software for Windows, Version 5. Statistical analyses were conducted
with SPSS (version 22, SPSS corporation, Chicago, IL, USA). Tests were two-
tailed. The level of nominal significance was set at Po0.05.
RESULTS
Distribution of TUB mRNA in the human hypothalamus
The expression pattern of TUB in the human hypothalamus was
determined by in situ hybridization using an LNA-2’-O-methyl-RNA
probe detecting both the short and the long transcripts of TUB.
Probe specificity was confirmed by the absence of staining with
the control-scrambled probe (Figure 1). To localize regions and
cells expressing TUB mRNA, consecutive sections of six hypotha-
lami (three men, three women) were analyzed (for subject
characteristics see Supplementary Table 1). Although considerable
inter-individual differences were observed in TUB mRNA staining
intensity, the staining distribution in the hypothalamus was similar
among individuals. No obvious effects of sex, age, fixation time
(up to 130 days) and post-mortem delay (up to 19:30 h) were
observed (data not shown). The distribution of TUB mRNA
expression in the hypothalamus was widespread with strongest
staining in the NBM (nucleus basalis of Meynert), neurons of the
PVN (paraventricular nucleus), SON (supraoptic nucleus) and TMN
(tuberomammillary nucleus) and less-intense staining in the IFN
(infundibular nucleus) (Figure 1, Supplementary Figure 2).
Hypothalamic expression of TUB in obese individuals and controls
We were not able to distinguish between the expression patterns
of the long and the short TUB isoforms using the in situ
hybridization approach. The expression of the two individual
TUB isoforms was therefore determined by RT–PCR using
hypothalami from 12 obese subjects and 12 controls
(Supplementary Tables 1 and 2). Both TUB transcripts were
Figure 1. Representative images of TUB mRNA expression in human hypothalamus. Tuberomammillary nucleus (TMN) neurons show intense
staining, whereas there is no specific staining with the control-scrambled probe. Staining is also visible in neurons in the infundibular nucleus
(IFN), nucleus basalis of Meynert (NBM), paraventricular nucleus (PVN), supraoptic nucleus (SON) and suprachiasmatic nucleus (SCN). Samples
derived from male (patient #97157). Scale bar= 25 μm.
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expressed in the hypothalamus, whereby the levels of the short
TUB isoform were markedly higher than those of the long TUB
isoform (Figure 2a). In addition, the expression levels of both
isoforms were highly correlated with each other (r= 0.58,
P= 0.003).
Because central defects in TUB function have been associated
with obesity in mice, we next examined the potential association
between human TUB mRNA levels in the hypothalamus and
obesity. For both TUB isoforms, however, there were no significant
differences in expression between obese and control subjects
(Figures 2b and c). As the quality of RNA taken from post-mortem
material may influence the gene expression profile, we assessed
whether the RQS values were affected by confounding factors. No
differences in the mean RQS values between obese individuals
(6.37 ± 0.24) and controls (6.48 ± 0.24) were found, indicating that
the quality of the RNA was similar in both groups (Supplementary
Figure 3).
TUB expression in adipose tissue
Because it is unknown whether TUB is expressed in human
adipose tissue, we assessed TUB mRNA levels in VAT and SAT in
two study (clinical characteristics in Table 1). In both fat depots,
only the short isoform of TUB was detected. In paired samples of
VAT and SAT taken from 49 subjects (15 controls and 34 severely
obese), we first looked at differences in TUB gene expression
between the two fat depots and observed higher TUBmRNA levels
in SAT than in VAT in both controls (n= 15 paired samples) and
obese individuals (n= 34 paired samples) as well as in the pooled
sample of both groups (mean± s.e.: SAT: 0.72 ± 0.07 vs VAT:
0.51 ± 0.08, P= 0.018) (Figure 3). To examine a potential effect of
gender on gene expression, we compared TUB mRNA levels
between men and women (in obese group) and found no
difference in either fat depot (data not shown). Next, in both SAT
and VAT, we found a clear indication of lower TUB expression in
obese subjects relative to controls (Po0.05) (Figure 4). This
difference was still observed, when the control group was
compared to the sex-matched obese group of women only
(Supplementary Figure 4).
In control subjects, we further observed negative correlations
between VAT TUB mRNA and weight (r=− 0.64, P= 0.002), BMI
(r=− 0.56, P= 0.009), waist circumference (r=− 0.66, P= 0.002) and
hip circumference (r=− 0.54, P= 0.017) (Table 2, Supplementary
Figure 5). Similar correlations were found for SAT TUB mRNA and
the same anthropometric characteristics but these were not as
strong. In contrast, in obese subjects we detected correlation
between BMI and SAT TUB mRNA (r=− 0.44, P= 0.004), but not
VAT TUB mRNA (r=− 0.15, P= 0.32). The analysis also revealed
significant relationships between TUB expression and different
metabolic traits in severely obese individuals, but not in controls
(Table 2): levels of SAT TUB mRNA were negatively correlated with
insulin levels (r=− 0.31, P= 0.047) and positively correlated with
high-density lipoprotein (HDL) cholesterol (r= 0.48, P= 0.002). We
also observed opposite trends in the direction of the correlations
between TUB mRNA in VAT and blood glucose in severely obese
patients (r=− 0.30, P= 0.046) and controls (r= 0.16, P= 0.50)
(Table 2). The sex-stratified analysis revealed that the observed
relationships between TUB expression in VAT and blood glucose
and TUB expression in SAT and HDL cholesterol were driven by the
stronger correlations in women (r=− 0.36, P= 0.035 and r= 0.44,
P= 0.012, respectively) as well as identified a new correlation
between TUB mRNA level and LDL cholesterol in men (r= 0.81,
P= 0.014) (Supplementary Table 3).
Expression of TUB in ASCs
To establish whether the expression of TUB in human adipocytes is
regulated by adiposity and/or adipose development, ASCs were
cultured in vitro and induced to differentiate into adipocytes. The
expression of both TUB isoforms was determined, as well as TUB
Figure 2. Measurement of TUB gene expression in the human hypothalamus. (a) Expression levels of the long and short isoforms in the
hypothalamus (n= 24); data plotted as mean± s.e.: 0.0021± 0.0002 vs 0.19± 0.013; Po0.0001. (b) Expression levels of the long isoform in 12
normal-weight controls (0.0020± 0.0003) and 12 obese individuals (0.0021± 0.0003). (c) Expression levels of the short isoform in 12 normal-
weight controls (0.19± 0.02) and 12 obese individuals (0.18± 0.02). Data plotted as mean± s.e.
Table 1. Clinical characteristics of study population used to study TUB
gene expression in adipose tissue
Characteristics Controls (N=24) Severely obese
individuals (N=53)
N Mean± s.d. N Mean± s.d.
Age (years) 24 45.2± 10.8 53 42.4± 9.0
Sex (male/female) 0/24 − 12/41 −
Weight (kg) 24 74.1± 11.2 − −
BMI (kg m− 2) 24 25.5± 3.3 53 46.8± 10.4
Waist (cm) 21 85.1± 9.6 − −
Hip (cm) 22 103.1± 8.5 − −
Glucose (mmol l− 1) 23 5.7± 0.8 53 6.2± 1.7
Insulin (pg ml− 1) 23 304.5± 129.6 52 138.2± 80.6
HbA1c (%) − − 52 6.4± 1.2
Total cholesterol (mmol l− 1) 23 2.6± 0.7 50 4.9± 0.9
HDL cholesterol (mmol l− 1) 23 1.2± 0.4 51 1.0± 0.3
LDL cholesterol (mmol l− 1) 23 4.2± 0.9 51 3.1± 0.8
Triglycerides (mmol l− 1) 23 1.5± 0.9 51 1.9± 1.2
Abbreviations: HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LDL,
low-density lipoprotein; TUB, Tubby gene.
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expression over time during differentiation. To assess the putative
effects of prolonged culture time on gene expression patterns,
undifferentiated cells were cultured alongside the differentiated
cells. Differentiation was assessed by visual assessment of lipid
droplets and quantified by assessing the expression of the
adipogenesis marker adipocyte protein 2 (aP2, FABP4)
(Supplementary Figures 6A and B). In line with the findings for
TUB expression in primary adipose tissue, ASCs (both differen-
tiated and undifferentiated) only expressed the short variant of
TUB (Supplementary Figure 7A). However, neither differentiation
of ASCs into mature adipocytes nor treatment with the metabolic
hormones insulin and triiodothyronine (T3) had an effect on the
expression levels of TUB in undifferentiated or differentiated ASCs
(Supplementary Figures 7B–D).
DISCUSSION
Defects in TUB gene function are known to cause metabolic
disturbances and the development of obesity in mice, yet the
relevance of TUB in human obesity is unclear. The results of this
study demonstrate that high levels of TUB are expressed in the
hypothalamus, especially in areas involved in body weight
regulation. We also show that TUB expression correlates negatively
with indices of body weight and obesity in a fat-depot-specific
manner. However, TUB expression in human adipocytes does not
appear to be modulated by metabolic hormones such as insulin.
These findings are discussed in more detail below.
TUB expression in the hypothalamus
Most of available knowledge on the mechanisms underlying the
phenotype of the Tubby mouse points toward aberration in the
control of body weight by the CNS.11 In rodents, TUB is abundantly
expressed in several areas of the hypothalamus, particularly in the
arcuate, PVN and ventromedial nuclei—regions that are involved
in the regulation of satiety and appetite.7,9,10 We observed similar
distribution pattern of TUB expression in the human hypothala-
mus. The highest levels of TUB mRNA were detected in the
neurons of the IFN—the human orthologue of the rodent
arcuate,33 and the PVN. Both the IFN/arcuate and the PVN are
hypothalamic regions necessary for the integration of homeostatic
signals that regulate energy balance.11 We also detected
expression of TUB in the suprachiasmatic nucleus and TMN, two
nuclei involved in the circadian control of energy metabolism in
humans; in the NBM, which is important for memory; and the SON,
which regulates water reabsorption.33 These expression patterns
for TUB are similar to those reported in the human hypothalamus
for three major regulators of energy homeostasis, namely
neuropeptide Y, agouti-related protein and the melanocortin-4
receptor.27,34 Our observations are also in line with the role of
Tubby in GPCR trafficking in the neuronal cilia,15,16 a cellular
compartment widely present in hypothalamic neurons and
involved in energy homeostasis.35 Altogether, these data support
the hypothesis that TUB is involved in the central regulation of
energy metabolism. The expression of TUB in NBM, SON,
suprachiasmatic nucleus and TMN, which has not been described
for the mouse orthologues of these nuclei, suggests species-
specific differences in hypothalamic TUB localization between
mice and humans.10
We did not find evidence for an association between TUB
expression levels in the hypothalamus and obesity. This could be
due to the relatively small sample size, caused by the limited
availability of high-quality frozen brain material from obese
individuals and well-matched controls. Also, since we used whole
hypothalami to assess gene expression levels, spatial differences
in expression could not be discerned. Finally, it is known that
obesity is a complex condition with a multifactorial background.
Figure 3. Measurement of TUB expression in two different adipose tissue depots. Expression of the TUB short isoform in paired samples from
visceral (VAT) and subcutaneous (SAT) adipose tissue: (a) In controls. Mean± s.e. for VAT: 0.72± 0.18; for SAT: 0.96± 0.16; P= 0.20 (n= 15). (b) In
obese individuals. Mean± s.e. for VAT: 0.42± 0.08; for SAT: 0.62± 0.06; P= 0.05 (n= 34). (c) In pooled sample of controls and obese individuals
(n= 49). Mean± s.e. for VAT: 0.51± 0.08; for SAT: 0.72± 0.07; P= 0.018.
Figure 4. TUB expression in adipose tissue depots of controls and
obese individuals. (a) Expression of the TUB short isoform in
subcutaneous adipose tissue (SAT). Mean± s.e. for controls (n= 18):
0.99± 0.16; for obese individuals (n= 41): 0.64± 0.06; P= 0.0068.
(b) Expression of TUB in visceral adipose tissue (VAT). Mean± s.e. for
controls (n= 21): 1.10± 0.28; for obese individuals (n= 46):
0.45± 0.07; P= 0.01. Data plotted as mean± s.e.
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Whereas mutations in TUB are known to cause syndromic obesity
in humans,23 moderate alterations in TUB function are not
necessarily a common feature of obesity. This notion is supported
by the observation that in three different mouse models of obesity
the expression of TUB does not significantly differ from that in
normal-weight controls.5 Further studies are needed to determine
whether hypothalamic TUB contributes to the development of
obesity in a subpopulation of patients and to what extent.
TUB expression in adipose tissue
In mice, TUB is expressed in a variety of insulin-sensitive peripheral
tissues,4,7 which suggests that the Tubby protein, besides its role
in the CNS may also have a peripheral function in energy
homeostasis. We chose to analyze TUB expression in adipose
tissue as it is the main depot for energy storage, and because it
has an important role in obesity pathophysiology.36 Although
both TUB splice variants were expressed in the hypothalamus, only
the short isoform of TUB was found in adipose tissue, suggesting
that TUB expression might be regulated in a tissue-specific
manner. Previous studies identified that the two Tubby isoforms
are similar in their COOH-terminal DNA binding domain, while are
distinct owing to the alternatively spliced NH2-terminal regions
that induce transcription activation.1,3 Boggon et al. identified
further that such alternative splicing does not affect the overall
character of Tubby protein but results in the difference to activate
transcription, a common mechanism of control in transcriptional
modulators.1 Together with these data, our findings indicate
differential regulation of transcription by the different TUB
isoforms in CNS and in adipose tissue.
We also observed fat-depot-specific differences in TUB expres-
sion, with TUB being expressed at higher levels in SAT than in VAT.
A similar expression pattern in adipose tissues has also been
reported for the FTO gene, a gene strongly implicated in human
obesity,37 suggesting similarity in fat-depot-specific properties
between the genes. Notably, we found a negative correlation
between TUBmRNA levels in adipose tissue and BMI in both obese
and non-obese individuals. However, in control subjects the levels
of TUB mRNA in VAT correlated the strongest with parameters of
body weight, whereas in obese individuals a stronger relationship
was found in SAT. More detailed analysis revealed a significant
reduction in TUB expression in the VAT of severely obese
individuals relative to controls. This is of particular interest as
excess VAT has been linked to a higher risk of metabolic
derangements.38
Next, in severely obese patients we found significant and
directionally consistent correlations between TUB mRNA levels
and blood glucose and lipid-related traits. Our data also suggest
gender-specific pattern in correlations between TUB expression
and metabolic profile of adipose tissue depots. This may indicate a
peripheral role for TUB in the regulation of metabolic homeostasis.
It should be noted, however, that from the present study design it
is not possible to determine whether the detected relationships
contribute to the causes of these metabolic changes or whether
they represent the obesity-driven consequences. Taking into
account our observations on the TUB expression in adipose tissue
and previously reported associations between the TUB common
variants and increased risk of obesity,21,22,39 as well as the obesity
phenotypes linked to the loss-of-function mutation in Tubby mice
or in C. elegans,3–5,19 we hypothesize the following: that metabolic
aspects of obesity can be affected by peripheral alterations in the
function of TUB.
Our experiments in human ASC-derived adipocytes showed
that TUB mRNA levels remain stable during differentiation. These
results suggest that adipocyte development is not a driver of TUB
expression in humans, whereas Stretton et al.20 reported a
differentiation-linked reduction in TUB expression in murine 3T3-
L1 adipocytes. Next, previous studies in rodent adipocytes and
neuronal cells40 have reported on the regulation of TUB expression
by insulin and T3, two important hormones in the regulation of
metabolism, but we were unable to reproduce these results in
human ASC-derived adipocytes. This discrepancy reflects the
complex aetiology of obesity, and that there are distinctive
differences between humans and rodents, as shown by similar
functional studies.41,42 Also, we cannot exclude the possibility that
a decrease in TUB expression increases adiposity, because of the
negative correlation between TUB mRNA levels and body weight
parameters observed in our study.
This work has several limitations. First, in this expression study
we used whole adipose tissue that is known to consist of multiple
cell types such as mature and pre-adipocytes, endothelial cells,
fibroblasts and a range of immune cells.43 Next, owing to
limitations in the availability of both adipose and hypothalamic
tissues we were not able to determine the levels of the Tubby
protein in the same sample sets. Therefore, we used a proteomics
approach to validate the TUB expression in human adipocytes. In
the available data of the human adipocyte proteome obtained
using a combination of different proteomics techniques44 Tubby
protein was not identified. This may be owing to a low abundance
of the protein and/or insufficient sensitivity of the used mass
Table 2. Correlations between clinical parameters and TUB gene expression in visceral and subcutaneous adipose tissues
Trait Controls Severely obese individuals
Visceral AT Subcutaneous AT Visceral AT Subcutaneous AT
n rs P-value n rs P-value n rs P-value n rs P-value
Weight 21 − 0.64 0.002 21 − 0.42 0.08 − − − − − −
BMI 21 − 0.56 0.009 18 − 0.37 0.13 46 − 0.15 0.32 41 − 0.44 0.004
Waist 19 − 0.66 0.002 16 − 0.48 0.06 − − − − − −
Hip 19 − 0.54 0.017 17 − 0.38 0.13 − − − − − −
Glucose 20 0.16 0.50 17 − 0.02 0.93 46 − 0.30 0.046 41 − 0.08 0.64
Insulin 20 − 0.26 0.27 17 0.09 0.72 45 − 0.16 0.29 41 − 0.31 0.047
HbA1c − − − − − − 45 − 0.26 0.08 40 -0.10 0.56
Total cholesterol 20 0.20 0.40 17 0.06 0.83 43 0.08 0.62 39 0.16 0.34
HDL cholesterol 20 0.11 0.65 17 − 0.01 0.96 44 0.28 0.07 40 0.48 0.002
LDL cholesterol 20 0.06 0.79 17 0.00 0.99 44 0.19 0.21 40 0.11 0.48
Triglycerides 20 − 0.31 0.19 17 − 0.23 0.37 44 − 0.28 0.07 40 −0.26 0.11
Abbreviations: AT, adipose tissue; BMI, body mass index; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TUB, Tubby gene.
rs, Spearman regression coefficient. P-valueso0.05 are indicated in bold.
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spectrometry analyses/sample processing to detect Tubby. Further
research investigating cell-specific expression of TUB and its
protein expression are needed to determine the exact role of TUB
in adipose and hypothalamic tissue metabolism and function.
CONCLUSIONS
Together, our findings are consistent with a role for TUB in energy
metabolism, and support the involvement of TUB in obesity in
humans, thereby providing insights into the enigmatic function
of the Tubby protein. Further molecular studies should reveal
how TUB affects body weight regulation, which will help to
improve preventive therapies and aid in the development of new
drugs and in the identification of subgroups of patients with
increased risk for obesity, and help to improve preventive
therapies.
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